Molecular and immune signatures, and pathological trajectories of fatal COVID‐19 lungs defined by in situ spatial single‐cell transcriptome analysis
Arun Das(University of Pittsburgh), Shou‐Jiang Gao(UPMC Hillman Cancer Center), Gabriel Sica(Emory University), Mario Flores(The University of Texas at San Antonio), Yu‐Chiao Chiu(The University of Texas at San Antonio Health Science Center), Clare Bryce(Icahn School of Medicine at Mount Sinai), Suzane Ramos da Silva(University of Pittsburgh), Zachary Grimes(Icahn School of Medicine at Mount Sinai), Wen Meng(China Agricultural University), Karla Paniagua Rivera(The University of Texas at San Antonio), Yufei Huang(The University of Texas at San Antonio), Emilia Mia Sordillo(Icahn School of Medicine at Mount Sinai), Carlos Cordon‐Cardo(Icahn School of Medicine at Mount Sinai), Hugh Galloway(University of Pittsburgh), Luping Chen(University of Pittsburgh), Zhentao Liu(Zhejiang Energy Research Institute), Md Musaddaqul Hasib(University of Pittsburgh), Alberto Paniz‐Mondolfi(Incubadora Venezolana de la Ciencia)
Cited by 18
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899